Integral Ad Science (NASDAQ:IAS) Stock Price Expected to Rise, Morgan Stanley Analyst Says

Integral Ad Science (NASDAQ:IAS) had its target price boosted by Morgan Stanley from $13.00 to $13.50 in a research note issued to investors on Monday morning,Benzinga reports. Morgan Stanley currently has an equal weight rating on the stock.

Several other research analysts have also weighed in on IAS. Oppenheimer reaffirmed an “outperform” rating on shares of Integral Ad Science in a report on Friday. Scotiabank initiated coverage on Integral Ad Science in a report on Friday. They issued a “sector perform” rating and a $12.00 target price on the stock. Craig Hallum decreased their price objective on shares of Integral Ad Science from $18.00 to $16.00 and set a “buy” rating on the stock in a research report on Wednesday, November 13th. Piper Sandler cut their price target on Integral Ad Science from $18.00 to $16.00 and set an “overweight” rating for the company in a report on Wednesday, November 13th. Finally, Barclays reaffirmed an “equal weight” rating on shares of Integral Ad Science in a research note on Friday. Four equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $15.06.

Integral Ad Science Price Performance

IAS stock opened at $10.72 on Monday. The business has a 50 day simple moving average of $10.34 and a 200-day simple moving average of $10.82. Integral Ad Science has a twelve month low of $7.98 and a twelve month high of $13.62. The company has a current ratio of 3.71, a quick ratio of 3.71 and a debt-to-equity ratio of 0.07. The company has a market capitalization of $1.74 billion, a P/E ratio of 53.60, a PEG ratio of 1.06 and a beta of 1.46.

Integral Ad Science (NASDAQ:IAS) last announced its quarterly earnings data on Friday, February 28th. The company reported $0.09 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.12 by ($0.03). Integral Ad Science had a net margin of 6.39% and a return on equity of 3.47%. The firm had revenue of $153.00 million during the quarter, compared to analyst estimates of $148.83 million. During the same period in the prior year, the firm posted $0.06 earnings per share. The business’s quarterly revenue was up 13.9% compared to the same quarter last year. As a group, equities analysts anticipate that Integral Ad Science will post 0.26 EPS for the current year.

Insiders Place Their Bets

In other news, CEO Lisa Utzschneider sold 12,448 shares of the firm’s stock in a transaction dated Tuesday, February 4th. The stock was sold at an average price of $10.61, for a total transaction of $132,073.28. Following the completion of the sale, the chief executive officer now directly owns 278,650 shares in the company, valued at $2,956,476.50. This trade represents a 4.28 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders sold a total of 19,109 shares of company stock worth $197,696 in the last 90 days. 2.00% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the business. US Bancorp DE boosted its stake in shares of Integral Ad Science by 540.9% during the 3rd quarter. US Bancorp DE now owns 35,776 shares of the company’s stock valued at $387,000 after buying an additional 30,194 shares during the last quarter. Stoneridge Investment Partners LLC bought a new position in Integral Ad Science during the 3rd quarter valued at $125,000. TimesSquare Capital Management LLC grew its holdings in Integral Ad Science by 0.6% during the 3rd quarter. TimesSquare Capital Management LLC now owns 2,772,440 shares of the company’s stock worth $29,970,000 after acquiring an additional 17,166 shares in the last quarter. Oppenheimer & Co. Inc. bought a new stake in shares of Integral Ad Science in the 3rd quarter worth about $281,000. Finally, Quest Partners LLC raised its stake in shares of Integral Ad Science by 101,255.9% in the 3rd quarter. Quest Partners LLC now owns 34,461 shares of the company’s stock valued at $373,000 after purchasing an additional 34,427 shares in the last quarter. Hedge funds and other institutional investors own 95.78% of the company’s stock.

About Integral Ad Science

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.